Reply to Passamonti et al: Ruxolitinib and survival improvement in patients with myelofibrosis

G. Barosi, R. P. Gale

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)740
Number of pages1
JournalLeukemia
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 9 2015

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine
  • Medicine(all)

Cite this